US Stock MarketDetailed Quotes

IPA ImmunoPrecise Antibodies

Watchlist
  • 0.648
  • -0.022-3.34%
Close Sep 27 16:00 ET
  • 0.650
  • +0.003+0.39%
Post 17:26 ET
18.08MMarket Cap-814P/E (TTM)

ImmunoPrecise Antibodies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ImmunoPrecise Antibodies Q1 2025 Earnings Date

Currency：CADSep 16, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
6.75M
5.26M
-1.49M
Miss Est.
+18.67%
-7.47%
-22.03%
EPS
-0.11
-0.15
-0.04
Miss Est.
+19.57%
-7.14%
-36.74%
Analyst Rating
Buy

Sep 27, 2024

ImmunoPrecise Antibodies Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CAD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 6.708M--
--2025/Q2-- / 6.439M--
Sep 16, 20242025/Q15.263M / 6.750M--
Jul 29, 20242024/Q46.459M / 6.530M--
Mar 14, 20242024/Q36.221M / 6.068M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 6.708M--
--2025/Q2-- / 6.439M--
Sep 16, 20242025/Q15.263M / 6.750M--
Jul 29, 20242024/Q46.459M / 6.530M--
Mar 14, 20242024/Q36.221M / 6.068M--

Unlock Free Earnings Estimates

ImmunoPrecise Antibodies Earnings Reports

  • ImmunoPrecise Antibodies | 6-K: Report of foreign private issuer (related to financial reporting)

    Sep 16 09:06 ET

  • ImmunoPrecise Antibodies | 6-K: Report of foreign private issuer (related to financial reporting)

    Sep 16 09:06 ET

  • ImmunoPrecise Antibodies | 6-K: Report of foreign private issuer (related to financial reporting)

    Sep 10 13:06 ET

  • ImmunoPrecise Antibodies | 20-F: FY2024 Annual Report

    Jul 29 08:44 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 27, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data